Cited by 31Sirtuins and Resveratrol in MedicinePhytochemicals and Antioxidant ActivitiesAlcohol Consumption and Health Effects

Dose response biology of resveratrol in obesity

Open access
Scapagnini, Giovanni, Davinelli, Sergio, Kaneko, Taku, Koverech, Guido, Koverech, Angela, Calabrese, Edward J., Calabrese, Vittorio·2014·Journal of Cell Communication and Signaling

Abstract

Obesity is a major health problem throughout the world, and it is increasing both in prevalence and severity. Pharmaceutical approaches developed for the treatment of obesity, despite short-term benefits, often are associated with rebound weight gain after the cessation of drug use and serious side effects deriving from the medication can occur. Resveratrol has been well recognized as an anti-obesity substance for its lipid-lowering function as well as calorie-restriction effect. This polyphenol induces hormetic dose responses in a wide range of biological models, affecting numerous endpoints of biomedical and therapeutic significance. From an hormetic standpoint, we will discuss the potential relevance of resveratrol in the management of obesity and related comorbid conditions, emphasizing its ability to control simultaneously various pathological mechanisms associated with obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12079-014-0257-3

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dietary resveratrol supplementation has anti-obesity effects, potentially by mimicking metabolic effects of long-term caloric restriction and improving adipose tissue function and insulin sensitivity in obese models.

    “Recent studies have also revealed anti-obesity effects of dietary resveratrol supplementation [82, 83], potentially by mimicking the metabolic effects of long-term caloric restriction [84] and improving adipose tissue function and insulin sensitivity in obese model [85].”
  • Molecular targets of resveratrol include PGC1α, SIRT1, NFκB, AMPK, FoxO3, and PPARγ, which are responsible for modulating mitochondrial activity.

    “Studies have demonstrated the characterization of molecular targets of resveratrol, including PGC1α, SIRT1, NFκB, AMPK, FoxO3, and PPARγ [16, 61, 85, 89], that are responsible for modulating mitochondrial activity.”
  • Resveratrol can influence gene expression by inducing changes that mimic those seen under calorie restriction conditions.

    “In particular, resveratrol can influence gene expression by inducing changes that mimic those seen under calorie restriction conditions [12].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [12]

  • Resveratrol may affect the activity of AMPK, SIRT-1, and PGC-1α, all altered in the metabolic abnormalities present in patients with obesity.

    “Resveratrol may affect the activity of various intracellular targets such as adenosine monophosphate-activated protein kinase (AMPK), the deacetylating enzyme sirtuin-1 (SIRT-1), and the peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), all altered in the metabolic abnormalities present in patients with obesity [12,13].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [12]

  • Resveratrol-induced AMPK phosphorylation appears to be high-dose dependent.

    “However, resveratrol-induced AMPK phosphorylation appears to be high-dose dependent [12].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Scapagnini, G., Davinelli, S., Kaneko, T., Koverech, G., Koverech, A., Calabrese, E. J., & Calabrese, V.
Affiliations
  • University of Molise (IT)
  • Oregon Health & Science University (US)
  • University of Catania (IT)
  • University of Massachusetts Amherst (US)
  • University of Sannio (IT)
Corresponding author
Calabrese, Vittorio
Venue
Journal of Cell Communication and Signaling
Publisher
Wiley
Published
2014-11-12
Volume
8
Issue
4
Pages
385-391
ISSN
  • 1873-9601 (ISSN-L)
  • 1873-961X
OpenAlex
W2056059444
Cited by
31
References
44
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 3
FWCI
1.87
Type
journal article
Language
en
Open access
Locations
  • Journal of Cell Communication and Signaling (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
resveratrol, obesity, hormesis, dose-response relationship, polyphenols, anti-obesity, lipid lowering, caloric restriction, obesity-related comorbidities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review